Selective inhibitors of cyclic AMP-specific phosphodiesterase: Heterocycle-condensed purines

Journal of Medicinal Chemistry

Volumn 40, Issue 20, 1997, Pages 3248-3253

  Sawanishi, Hiroyuki ^a   Suzuki, Hirokazu ^a   Yamamoto, Shinya ^a   Waki, Yoshihiro ^b   Kasugai, Shohei ^c   Ohya, Keiichi ^c   Suzuki, Nagao ^b   Miyamoto, Ken Ichi ^b   Takagi, Kenzo ^d  

^a HOKURIKU UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIPROPYL 4,5,7,8 TETRAHYDRO 3H IMIDAZO[1,2 I]PURIN 5 ONE; DENBUFYLLINE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; PURINE DERIVATIVE; ROLIPRAM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONOTROPISM; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME INHIBITION; ISOLATED HEART; MOUSE; MUSCLE RELAXATION; NONHUMAN; ORAL DRUG ADMINISTRATION; TRACHEA MUSCLE; VOMITING;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ADMINISTRATION, ORAL; ANIMALS; DEPRESSION, CHEMICAL; HEART; ISOENZYMES; MALE; MODELS, CHEMICAL; MUSCLE RELAXATION; MYOCARDIUM; PHOSPHODIESTERASE INHIBITORS; PURINES; SHREWS; TRACHEA;

EID: 0030866070     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970089s     Document Type: Article

References (25)

1. Beavo, J. A. Cyclic nucleotide phosphodiesterase: Functional implications of multiple isoforms. Physiol. Rev. 1995, 75, 725- 748.
2. Spagnoli, A.; Tognoni, G. Cerebroactive drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders. Drugs 1983, 26, 44-69.
3. Wachtel, H. Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors. Neuropharmacology 1983, 22, 267-272.
4. Grome, J. J.; Stefanovich, V. In Adenosine: Receptors and Modulation of Cell Function; Stefanovich, V., Rudolphi, K., Schubert, P., Eds.; IRL Press: Oxford, 1985; pp 453-457.
5. O'Connolly, M.; Dierdorf, D.; Greb, W. H.; Mayer, E. R.; Wolf, D. Efficacy of denbufylline in patients with multi-infarct dementia. Drug Dev. Rev. 1988, 14, 195-198.
6. Torphy, T. J.; Undem, B. J. Phosphodiesterase inhibitors: New opportunities for the treatment of asthma. Thorax 1991, 46, 512-523.
7. Giembycz, M. A. Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma? Biochem. Pharmacol. 1992, 43, 2041-2051.
8. Chan, S. C.; Li, S.-H.; Hanifin, J. M. Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition. J. Invest. Dermatol. 1993, 100, 681-684.
9. Miyamoto, K.; Kurita, M.; Sakai, R.; Sanae, F.; Wakusawa, S.; Takagi, K. Cyclic nucleotide phosphodiesterase isoenzymes in guinea-pig tracheal muscle and bronchorelaxation by alkylxanthines. Biochem. Pharmacol. 1994, 48, 1219-1223.
10. Palacios, J. M.; Beleta, J.; Segarra, V. Second messenger systems as targets for new therapeutic agents: Focus on selective phosphodiesterase inhibitors. Il Farmaco 1995, 50, 819-827.
11. Wachtel, H. Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3′:5′-monophosphate phosphodiesterase inhibitors. Psychopharmacology 1982, 77, 309-316.
12. Hebenstreit, G. F.; Fellerer, K.; Fichte, K.; Fischer, G.; Geyer, N.; Meya, U.; Sastre-y-Hernandez, M.; Schony, W.; Schrazer, M.; Soukop, W.; Trampitsch, E.; Varosanee, S.; Zawada, E.; Zochling, R. Rolipram in major depressive disorder: results of a double- blind comparative study with imipramine. Pharmacopsychiatry 1989, 22, 156-160.
13. Howell, R. E.; Muehsam, W. T.; Kinnier, W. J. Mechanism for the emetic side effect of xanthine bronchodilators. Life Sci. 1990, 46, 563-568.
14. Persson, C. G. A.; Andersson, K. E.; Kjellin, G. Effects of enprofylline and theophylline may show the role of adenosine. Life Sci. 1986, 38, 1057-1072.
15. Miyamoto, K.; Sakai, R.; Kurita, M.; Ohmae, S.; Sanae, F.; Sawanishi, H.; Hasegawa, T.; Takagi, K. Effects of alkyl substituents of xanthine on phosphodiesterase isoenzymes. Biol. Pharm. Bull. 1994, 18, 431-434.
16. Miyamoto, K.; Kurita, M.; Ohmae, S.; Sakai, R.; Sanae, F.; Takagi, K. Selective tracheal relaxation and phosphodiesterase- IV inhibition by xanthine derivatives. Eur. J. Pharmacol. 1994, 267, 317-322.
17. Sakai, R.; Konno, K.; Yamamoto, Y.; Sanae, F.; Takagi, K.; Hasegawa, T.; Iwasaki, N.; Kakiuchi, M.; Kato, H.; Miyamoto, K. Effects of alkyl substitutions of xanthine skeleton on bronchodilation. J. Med. Chem. 1992, 35, 4039-4044.
18. 5O: C, 49.73; H, 5.74; N, 36.25. Found: C, 49.65; H, 5.73; N, 36.27.
19. Reeves, M. L.; Leigh, B. K.; England, P. J. The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle: Implications for the mechanism of action of selective phosphodiesterase inhibitors. Biochem. J. 1987, 241, 535-541.
20. Silver, P. J.; Hamel, L. T.; Perrone, M. H.; Bentley, R. G.; Bushover, C. R.; Evans, D. B. Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle. Eur. J. Pharmocol. 1988, 150, 85-94.
21. Nicholson, C. D.; Jackman, S. A.; Wilke, R. The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site. Br. J. Pharmacol. 1989, 97, 889-897.
22. Schneider, H. H.; Schmiechen, R.; Brezinski, M.; Seidler, J. Stereospecific binding of the antidepressant rolipram to brain protein structures. Eur. J. Pharmacol. 1986, 127, 105-115.
23. Ueno, S.; Matsuki, N.; Saito, H. Suncus murinus: A new experimental model in emesis research. Life Sci. 1987, 41, 513- 518.
24. 3H]rolipram binding activity and their relationship to emetic behavior in the ferret. J. Med. Chem. 1996, 39, 120-125.
25. Thompson, W. J.; Appleman, M. M. Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry 1971, 10, 311-316.